Riverview Capital Advisers’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
Other funds holding LH
Riverview Capital Advisers's LH Position: Q3 2026 in Review
Riverview Capital Advisers increased its Labcorp (LH) stake by 0.23% in Q3 2026, buying an estimated $4.96K and bringing the position to 6,957 shares worth $2.14M. The position accounts for 0.61% of the portfolio, ranked #35.
Riverview Capital Advisers first reported a position in LH in Q4 2021 and has held it in 20 quarters since. The position peaked at $2.51M in Q4 2021. 1,095 funds tracked by Wall St. Rank hold LH as of Q3 2026.
- Riverview Capital Advisers held 6,957 shares of Labcorp worth $2.14M as of Q3 2026.
- Riverview Capital Advisers bought 16 Labcorp shares in Q3 2026, an estimated $4.96K.
- Labcorp made up 0.61% of Riverview Capital Advisers's portfolio in Q3 2026, its #35 holding.
- Riverview Capital Advisers first reported a position in Labcorp in Q4 2021 and has held it in 20 quarters since.
- Riverview Capital Advisers's Labcorp position peaked at $2.51M in Q4 2021.
- 1,095 funds tracked by Wall St. Rank held Labcorp as of Q3 2026.
Based on Riverview Capital Advisers's 13F filing for Q3 2026, filed 12 Nov 2026.